(Q39296389)

10 September 2017

title

Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project (English)

1 reference

10 September 2017

4

Li Li

1 reference

10 September 2017

Weizhong Yang

1

1 reference

10 September 2017

Xiaofeng Liang

2

1 reference

10 September 2017

Fuqiang Cui

3

1 reference

10 September 2017

Stephen C Hadler

5

1 reference

10 September 2017

Yvan J Hutin

6

1 reference

10 September 2017

Mark Kane

7

1 reference

10 September 2017

Yu Wang

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 December 2013

1 reference

10 September 2017

1 reference

10 September 2017

volume

31 Suppl 9

1 reference

10 September 2017

page(s)

J73-8

1 reference

Origins, design and implementation of the China GAVI project

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Evaluation of immunization injection safety in China, 2010: achievements, future sustainability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Hepatitis B vaccines: WHO position paper--recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

Hepatitis B immunoprophylaxis: developing a cost-effective program in the hospital setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.060

10.1016/J.VACCINE.2012.09.060

7 January 2021

Identifiers

DOI

1 reference

release_7mvd4cueffhyfhl6feuhjtue2y

10 September 2017

Fatcat ID

0 references

1 reference